R68070, a combined thromboxane/endoperoxide receptor antagonist (TRA) and thromboxane synthase inhibitor (TSI), prolongs the bleeding time more than aspirin in man

Prog Clin Biol Res. 1989:301:573-7.
No abstract available

Publication types

  • Clinical Trial
  • Comparative Study

MeSH terms

  • Aspirin / pharmacology
  • Bleeding Time
  • Blood Platelets / drug effects*
  • Blood Platelets / physiology
  • Clinical Trials as Topic
  • Cyclic AMP / blood
  • Double-Blind Method
  • Humans
  • In Vitro Techniques
  • Male
  • Pentanoic Acids / pharmacology*
  • Prostaglandins / blood
  • Pyridines / pharmacology*
  • Random Allocation
  • Receptors, Prostaglandin
  • Receptors, Thromboxane
  • Thromboxane-A Synthase / antagonists & inhibitors*
  • Valerates / pharmacology*

Substances

  • Pentanoic Acids
  • Prostaglandins
  • Pyridines
  • Receptors, Prostaglandin
  • Receptors, Thromboxane
  • Valerates
  • Cyclic AMP
  • Thromboxane-A Synthase
  • ridogrel
  • Aspirin